SCHEMBL926836

SCHEMBL926836

CC(C)(C)c1ccc(S(=O)(=O)N2c3ccccc3C[C@H]2C(=O)NCc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 1/20 0.48
LMNA P02545 5/20 0.48
ALDH1A1 P00352 3/20 0.47
GLA P06280 1/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 2/20 0.46
RAB9A P51151 1/20 0.46
MEN1 O00255 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
XIAP P98170 2/20 0.45
RORC P51449 3/20 0.44
GAA P10253 1/20 0.43
PTGER3 P43115 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926246 0.93 EPHX2 (0.48) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL925329 0.93 EPHX2 (0.47) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL926437 0.92 LMNA (0.47) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL927263 0.92 LMNA (0.49) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL926069 0.92 NR1H4 (0.48) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL929513 0.91 LMNA (0.43) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL926636 0.90 CA1 (0.47) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL926338 0.90 FKBP1A (0.49) FKBP1AALDH1A1RAB9AMEN1KMT2A
SCHEMBL928082 0.90 PSEN1 (0.51) FKBP1ALMNAALDH1A1GLAPKM
SCHEMBL926489 0.89 FKBP1A (0.52) FKBP1AALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872021-B2 LXR receptor modulators LABORATORIES FOURNIER S.A. (FR) 2011-01-18 US disclosed
US-20070099960-A1 LXR receptor modulators LABORATOIRES FOURNIER S.A. (FR) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099960-A1 LXR receptor modulators NR1H2, NR1H3, PPARD FKBP1A 2748/4885LMNA 1809/4885ALDH1A1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.